BAKER BROS. ADVISORS LP 13D and 13G filings for Immunocore Holdings plc:
- Schedule 13D must be filed within ten days after a person or an organization acquires beneficial ownership of more than 5% of a voting class of a company's equity securities.
- Shares have been adjusted for stock splits.
| Reported DateTime | Transaction Date | Type | Company Symbol | Filed By Symbol | Shares Owned % Owned | Shares Vs. Prev Report | View |
| 2024-02-01 5:25 pm Sale | 2024-01-30 | 13D | Immunocore Holdings plc IMCR | BAKER BROS. ADVISORS LP | 2,452,871 4.990% | -2,232,819 (-47.65%) | Filing |
| 2022-07-20 5:12 pm Purchase | 2022-07-15 | 13D | Immunocore Holdings plc IMCR | BAKER BROS. ADVISORS LP | 4,685,690 9.930% | 1,333,333 (+39.77%) | Filing |
| 2021-05-20 5:25 pm Unchanged | 2021-05-10 | 13D | Immunocore Holdings plc IMCR | BAKER BROS. ADVISORS LP | 3,352,357 7.700% | 0 (Unchanged) | Filing |
| 2021-02-16 4:58 pm Purchase | 2021-02-16 | 13G | Immunocore Holdings plc IMCR | BAKER BROS. ADVISORS LP | 3,352,357 7.500% | 3,352,357 (New Position) | Filing |